{"title":"Effects of cardiac rehabilitation on obese hypertensive patients: A controlled trial","authors":"H. Baykal Sahin , M. Sahin","doi":"10.1016/j.hipert.2023.05.007","DOIUrl":"10.1016/j.hipert.2023.05.007","url":null,"abstract":"<div><h3>Introduction</h3><p>The relationship between obesity and hypertension is clearly known and cardiac rehabilitation (CR) is shown as an effective treatment method in both obese and hypertensive patients. The aim of this study is to reveal the effect of CR on obese hypertensive patients by comparing them with non-obese hypertensive patients.</p></div><div><h3>Methods</h3><p>Eighty eligible, volunteer participants with hypertension (SBP ≥140<!--> <!-->mmHg and/or DBP ≥90<!--> <!-->mmHg) were enrolled in this study. The patients were divided into 2 groups according to their BMI values: obese (BMI ≥30<!--> <!-->kg/m<sup>2</sup>) hypertensive patients and non-obese (BMI <30<!--> <!-->kg/m<sup>2</sup><span>) hypertensive patients. The CR program, in which aerobic exercise training was the main part, was performed on the patients. At the end of the 10-week CR program, the resting SBP and DBP values were measured.</span></p></div><div><h3>Results</h3><p>A total of 74 patients (37 obese and 37 non-obese) completed the study. After CR significant improvements were achieved in all evaluated parameters compared to pre-CR values. When the amounts of changes before and after CR were compared, the decrease in SBP was found to be significantly higher in obese patients compared to non-obese patients (<em>p</em> <!-->=<!--> <!-->.003). Higher BMI was associated with more reduction in SBP (<em>r</em> <!-->=<!--> <!-->0.287, <em>p</em> <!-->=<!--> <!-->0.013).</p></div><div><h3>Conclusions</h3><p>Exercise-based CR effectively reduced SBP in obese and non-obese hypertensive patients. However, it was more effective in obese patients compared to non-obese patients.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 197-204"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138048144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Minoxidil oral sin relación con la hipertensión arterial: incidencias por su uso creciente","authors":"C. Albaladejo Blanco , R. Alonso Martínez","doi":"10.1016/j.hipert.2023.11.002","DOIUrl":"10.1016/j.hipert.2023.11.002","url":null,"abstract":"","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 228-230"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Successful treatment of multidrug-resistant hypertension with catheter-based renal denervation in a patient with a renal artery stent","authors":"C. Yılmaz , B. Güvendi Şengör , R. Zehir","doi":"10.1016/j.hipert.2023.04.004","DOIUrl":"10.1016/j.hipert.2023.04.004","url":null,"abstract":"<div><p><span>Renal artery<span> stenting (RAS) and its effectiveness in the treatment<span> of atherosclerotic renal artery disease are controversial.</span></span></span><span><sup>1</sup></span><span> Catheter-based renal denervation (RDN) has been shown to reduce blood pressure in the treatment of multidrug-resistant hypertension.</span><span><sup>2</sup></span><span> In this case, we presented the successful regulation of multidrug resistant hypertension after renal denervation in a patient with renal artery stent.</span></p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 225-227"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9844368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Síntomas del tracto urinario inferior en pacientes con hipertensión arterial. Riesgo cardiovascular e impacto en su calidad de vida","authors":"M. Diosdado-Figueiredo","doi":"10.1016/j.hipert.2023.05.008","DOIUrl":"10.1016/j.hipert.2023.05.008","url":null,"abstract":"<div><h3>Objetives</h3><p>To determine the prevalence of erectile lower urinary tract symptoms in hypertensive patients, cardiovascular risk and the impact on quality of life.</p></div><div><h3>Material and methods</h3><p>Setting: Health Center (Vilagarcia, Pontevedra).</p><p>Period: April 2015-June 2017.</p><p>Inclusion criteria: Hypertensive patient with informed consent.</p></div><div><h3>Measurements</h3><p>sociodemographic variables, toxic habits, comorbidity, blood pressure, cardiovascular risk, analytical and examination parameters. Questionaries: International Prostate Symptom Scale (IPSS), International Index of Erectile Function (IIEF-15) and quality of life in arterial hypertension (MINICHAL).</p><p>Sample size: n<!--> <!-->=<!--> <!-->262 (± 6% accuracy, 95% confidence).</p><p>Statistical analysis: Bivariate and multivariate statistical analysis.</p><p>Informed consent and ethics committee approval were obtained (2024/237)</p></div><div><h3>Results</h3><p>The mean age was 65.84 (12.70), and mean hypertension duration of 13.25 (9.84) years. 76.7% reported lower tract urinary symptoms, 91.6% being mild. The bivariate analysis showed an association with the variables: age, educational level, profession, work activity, tobacco, benign prostatic hypertrophy, years of diagnosis, concomitant medication, Framingham-Wilson score, electrocardiogram, glycated hemoglobin, glomerular filtration (Crockroft-Gault), LDL-cholesterol, somatic manifestations (MINICHAL), erectile dysfunction. The multivariate analysis showed increased risk with:abdominal obesity, pathological electrocardiogram, high risk of Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents and decreased with not smoking and use diuretics.</p></div><div><h3>Conclusions</h3><p>Three quarters of hypertensive men presented lower urinary tract symptoms, increasing the risk of cardiovascular disease early according to the Framingham-Wilson score. Other predictive factors were: abdominal obesity, tobacco, pathological electrocardiogram, high Framingham-Wilson score, erectile dysfunction, use of hypouricemics agents.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 205-214"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138048143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Rosendo-Silva , A.C. Ortigosa-Ferreira , F. Prazeres , F. Caramelo , L.M. Santiago , I. Rosendo
{"title":"Systematic review of motivational interventions to improve adherence to medication in patients with hypertension and meta-analysis","authors":"B. Rosendo-Silva , A.C. Ortigosa-Ferreira , F. Prazeres , F. Caramelo , L.M. Santiago , I. Rosendo","doi":"10.1016/j.hipert.2023.04.003","DOIUrl":"10.1016/j.hipert.2023.04.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Antihypertensive medication non-adherence is an important cause of poor control in hypertension. The role of motivational interventions to increase antihypertensive medication adherence remains unclear.</p></div><div><h3>Objective</h3><p>To systematically review RCTs of motivational interventions for improving medication adherence in hypertension.</p></div><div><h3>Methods</h3><p>EMBASE and Pubmed were searched from inception to February 2019 for RCTs of motivational interventions for improving medication adherence in hypertension vs. usual care. Inclusion criteria: RCTs with motivational intervention to improve medication adherence in adults with hypertension. A blinded review was conducted by 2 reviewers. Disagreements were resolved by consensus/a third reviewer.</p><p>Data extraction and quality appraisal was performed using the risk of bias tool from cochrane collaboration. The meta-analyses of blood pressure control used random-effects models to report mean difference and 95% CIs. Primary outcome was medication adherence and second outcome was blood pressure control.</p></div><div><h3>Results</h3><p>The search methodology yielded 10 studies comprising 1171 participants. Medication adherence improved significantly in 5 studies. We could not perform pool analysis for this outcome due to different measurements of medication adherence. Seven trials reported significant results regarding blood pressure control.</p><p>On pooled analysis, motivational interventions were not significantly associated with a systolic blood pressure (mean difference, −0.06; 95% CI, −0.05 to 0.18; <em>p</em> <!-->=<!--> <!-->0.63; <em>I</em><sup>2</sup> <!-->=<!--> <!-->0.0%) or diastolic blood pressure (mean difference, −0.11; 95% CI, −0.10 to 0.31; <em>p</em> <!-->=<!--> <!-->0.28; <em>I</em><sup>2</sup> <!-->=<!--> <!-->23.8%) decrease or blood pressure control.</p></div><div><h3>Conclusions</h3><p>Motivational interventions seem to significantly improve medication adherence but not significantly blood pressure control in hypertension, although evidence is still being based on few studies, with unclear risk of bias.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 4","pages":"Pages 174-196"},"PeriodicalIF":0.6,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1889183723000259/pdfft?md5=3eaeb2e3ab65a9a5dda7a4a2305e3f02&pid=1-s2.0-S1889183723000259-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136094413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Roca Oporto, A. Luna Aguilera, G. Montilla Cosano, C. Andrades Gómez
{"title":"Hipertensión como elemento común de trasplante renal con riñón presor y del síndrome de encefalopatía posterior reversible","authors":"F. Roca Oporto, A. Luna Aguilera, G. Montilla Cosano, C. Andrades Gómez","doi":"10.1016/j.hipert.2023.03.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2023.03.001","url":null,"abstract":"<div><p>Secondary arterial hypertension accounts for only 5-10% of cases of arterial hypertension, hence the importance of its clinical suspicion for diagnosis. One of the most common causes of secondary hypertension is renovascular hypertension, caused by renal hypoperfusion and activation of the renin-angiotensin-aldosterone system. In addition to arterial hypertension being one of the most prevalent cardiovascular risk factors in the population, its poor control can cause acute neurological disorders such as Posterior Reversible Leukoencephalopathy syndrome (PRES), being characteristic the appearance of visuals alterations. Next, we present the case of a kidney transplant patient with well-controlled arterial hypertension with worsening secondary to renal artery stenosis and development of PRES.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 3","pages":"Pages 154-157"},"PeriodicalIF":0.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50179848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Soldevila , E. Vinyoles , A. Tobias , M.Á. Muñoz-Pérez , M. Gorostidi , A. de la Sierra
{"title":"Effect of air pollutants on ambulatory blood pressure","authors":"N. Soldevila , E. Vinyoles , A. Tobias , M.Á. Muñoz-Pérez , M. Gorostidi , A. de la Sierra","doi":"10.1016/j.hipert.2023.01.001","DOIUrl":"10.1016/j.hipert.2023.01.001","url":null,"abstract":"<div><h3>Background and methodology</h3><p>Air pollutants have a significant impact on public health.</p><p><span><span>The aim of the study was to find out the relationship between ambulatory blood pressure measured by 24-h </span>ambulatory blood pressure monitoring (ABPM) and the atmospheric pollutants that are measured regularly (PM</span><sub>10</sub>, PM<sub>2.5</sub>, NO<sub>2</sub> and SO<sub>2</sub><span>). An observational study of temporal and geographic measurements of individual patients (case-time series design) was carried out in Primary Care Centres and Hypertension Units in the Barcelona metropolitan area. We included 2888 hypertensive patients</span> <!-->≥<!--> <!-->18 years old, untreated, with a first valid ABPM performed between 2005 and 2014 and with at least one air pollution station within a radius of <3<!--> <!-->km.</p></div><div><h3>Results and conclusions</h3><p><span>The mean age was 54.3 (SD 14.6) years. 50.1% were women and 16.9% of the sample were smokers. Mean 24-h blood pressure (BP) was 128.0 (12.7)/77.4 (9.7) mmHg. After adjusting for mean ambient temperature and different risk factors, a significant association was found between ambulatory diastolic BP (DBP) and PM</span><sub>10</sub> concentrations the day before ABPM. For each increase of 10<!--> <!-->μg/m<sup>3</sup> of PM<sub>10</sub>, an increase of 1.37<!--> <!-->mmHg 24-h DBP and 1.48<!--> <!-->mmHg daytime DBP was observed. No relationship was found between PM<sub>2.5</sub>, NO<sub>2</sub> and SO<sub>2</sub> and ambulatory BP, nor between any pollutant and clinical BP.</p><p>The concentration of PM<sub>10</sub> the day before the ABPM is significantly associated with an increase in 24-h DBP and daytime DBP.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":"40 3","pages":"Pages 119-125"},"PeriodicalIF":0.6,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41139040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}